NSC |
Compound |
Enrichment |
Correlation |
NSC 720732 |
6,7-dimethyl-1,4-di-N-oxide-3-methylquinoxalin-2-yl-4-(4-nit rophenyl)piperazinyl ketone |
0.0385613993886 |
-0.31946572 |
NSC 733755 |
Null |
0.0385613993886 |
0.40003567 |
NSC 734982 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.0385613993886 |
-0.44830303 |
NSC 747180 |
Null |
0.0385613993886 |
-0.35138903 |
NSC 750104 |
5,10-dimethoxybenzo[g]quinolin-2(1H)-one |
0.0385613993886 |
0.071057363 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0385613993886001 |
0.41453643 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0385613993886001 |
0.19527504 |
NSC 13151 |
Null |
0.0385613993886001 |
0.19764775 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0385613993886001 |
0.080010334 |
NSC 303861 |
L-Cysteine analog |
0.0385613993886001 |
0.47086701 |